A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I): Effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB

The novel meningococcal serogroup B vaccine (4CMenB, Bexsero(®)), recently approved in Europe and Australia, may soon be included in routine infant immunization schedules, subject to guidance from national or regional recommending bodies. In the development of 4CMenB and consistent with other newly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Prymula, Roman, Esposito, Susanna, Zuccotti, Gian Vincenzo, Xie, Fang, Toneatto, Daniela, Kohl, Igor, Dull, Peter M
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4186040/
https://ncbi.nlm.nih.gov/pubmed/25424809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28666
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados